Literature DB >> 10617749

Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines.

M B Rennels1, M A Deloria, M E Pichichero, G A Losonsky, J A Englund, B D Meade, E L Anderson, M C Steinhoff, K M Edwards.   

Abstract

BACKGROUND: Diphtheria and tetanus toxoid combined with acellular pertussis (DTaP) vaccines are less reactogenic than diphtheria and tetanus toxoid combined with whole cell pertussis (DTwP) vaccines. However, local reactions increase in rate and severity with each successive DTaP dose, and swelling of the entire injected limb has been reported after booster doses.
METHODS: We reviewed reports of swelling of the entire thigh or upper arm after the fourth and fifth dose, respectively, of DTaP vaccines administered in the National Institutes of Health multicenter comparative DTaP studies. Relationships were explored among reports of severe swelling, rates of other reactions, quantity of vaccine contents, and prevaccination and postvaccination antibody levels to pertussis toxin, tetanus toxin, and diphtheria toxin.
RESULTS: Entire thigh swelling was an unsolicited reaction reported in 20 (2%) of the 1015 children who received 4 consecutive doses of the same DTaP vaccine. The reaction was associated with 9 of the 12 DTaP vaccines evaluated. Although there were no reports of swelling of the entire upper arm in 121 children given a fifth dose of the same DTaP, 4 (2.7%) of 146 recipients of 5 doses of a mixed schedule of DTaP vaccines experienced such swelling. Rates of other reactions were higher in children with entire thigh swelling than in those without. Of the children with entire thigh swelling, 60% had local pain, and 60% had erythema. All swelling subsided spontaneously without sequelae. There was a significant linear association between the rates of entire thigh swelling after dose 4 and diphtheria toxoid content in the DTaP products. Lesser degrees of swelling (>50 mm but less than entire limb) correlated with pertussis toxoid content after dose 4 and aluminum content after dose 5. No relationship was established between levels of serum antibody to diphtheria, tetanus, or pertussis toxin and rates of swelling of the whole thigh.
CONCLUSIONS: Booster doses of DTaP vaccines can cause entire limb swelling, which is usually associated with redness and pain. Our data suggest that this extensive swelling reaction may be more common with vaccines containing high diphtheria toxoid content.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10617749     DOI: 10.1542/peds.105.1.e12

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  13 in total

1.  Pulmonary immunization of guinea pigs with diphtheria CRM-197 antigen as nanoparticle aggregate dry powders enhance local and systemic immune responses.

Authors:  Pavan Muttil; Brian Pulliam; Lucila Garcia-Contreras; John Kevin Fallon; Chenchen Wang; Anthony James Hickey; David A Edwards
Journal:  AAPS J       Date:  2010-09-28       Impact factor: 4.009

Review 2.  When should vaccination be contraindicated in children?

Authors:  Laura Lane; Arlene Reynolds; Mary Ramsay
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  Pertussis vaccination for health care workers.

Authors:  Thomas J Sandora; Courtney A Gidengil; Grace M Lee
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

4.  Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine.

Authors:  Natasha B Halasa; Alice O'Shea; Jian R Shi; Bonnie J LaFleur; Kathryn M Edwards
Journal:  J Pediatr       Date:  2008-04-28       Impact factor: 4.406

5.  Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children.

Authors:  Julie Rowe; Stephanie T Yerkovich; Peter Richmond; Devinda Suriyaarachchi; Elizabeth Fisher; Leonie Feddema; Richard Loh; Peter D Sly; Patrick G Holt
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

6.  Surveillance for adverse events following immunization from 2008 to 2011 in Zhejiang Province, China.

Authors:  Yu Hu; Qian Li; Luoya Lin; Enfu Chen; Yaping Chen; Xiaohua Qi
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

Review 7.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

8.  Investigation in a murine model of possible mechanisms of enhanced local reactions to post-primary diphtheria-tetanus toxoid boosters in recipients of acellular pertussis-diphtheria-tetanus vaccine.

Authors:  Masaki Ochiai; Yoshinobu Horiuchi; Chun-Ting Yuen; Catpagavalli Asokanathan; Akihiko Yamamoto; Kenji Okada; Michiyo Kataoka; Kevin Markey; Michael Corbel; Dorothy Xing
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 9.  Acellular pertussis vaccine safety and efficacy in children, adolescents and adults.

Authors:  Janet R Casey; Michael E Pichichero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

10.  Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study.

Authors:  Lisa A Jackson; Onchee Yu; Edward A Belongia; Simon J Hambidge; Jennifer Nelson; Roger Baxter; Allison Naleway; Charlene Gay; James Nordin; James Baggs; John Iskander
Journal:  BMC Infect Dis       Date:  2009-10-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.